Cargando…
Pembrolizumab Induced Calcitriol-Mediated Hypercalcemia
PD-1/PD-L1 inhibitors such as pembrolizumab have radically improved the prognosis for many patients with advanced malignancies. Although revolutionary, its use can be complicated and limited by various immune-related adverse effects. Effective management depends on early recognition and prompt inter...
Autores principales: | Oommen, Tiffany T., Sun, Kelly, Barranco-Trabi, Javier, Berenberg, Jeffrey, Kim, Myungjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839403/ https://www.ncbi.nlm.nih.gov/pubmed/36644340 http://dx.doi.org/10.1155/2023/9160326 |
Ejemplares similares
-
Silicone-Induced Granuloma after Injection for Cosmetic Purposes: A Rare Entity of Calcitriol-Mediated Hypercalcemia
por: Agrawal, Nidhi, et al.
Publicado: (2013) -
Steroid responsive idiopathic calcitriol induced hypercalcemia: a case report and review of the literature
por: Fadel, Omar El, et al.
Publicado: (2023) -
Calcitriol induced hypercalcemia - a rare phenomenon in lung cancer: A case report
por: Prakash, Amulya, et al.
Publicado: (2023) -
SAT-502 Bisphosphonates for Treatment of Calcitriol-Induced Hypercalcemia
por: Mateo, Roselyn Cristelle, et al.
Publicado: (2019) -
Hypercalcemia associated with dysgerminoma and elevation of calcitriol: A case report and review of the literature
por: Hara, Natsuko, et al.
Publicado: (2022)